Home/Filings/4/0001437749-12-001707
4//SEC Filing

Stroman David W. 4

Accession 0001437749-12-001707

CIK 0001389545other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:38 PM ET

Size

5.1 KB

Accession

0001437749-12-001707

Insider Transaction Report

Form 4
Period: 2012-02-17
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
  • Award

    Option (Right to Buy)

    2012-02-17+7,823207,823 total
    Exercise: $1.44From: 2012-03-30Exp: 2022-02-17Common Stock (7,823 underlying)
Footnotes (1)
  • [F1]The options will vest and become exercisable in four equal installments: Twenty-five percent (25%) each on March 30, 2012, June 30, 2012, September 30, 2012 and December 30, 2012.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001532040

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:38 PM ET
Size
5.1 KB